Wockhardt founder and chairman Habil F Khorakiwala says the company has also invited the regulator to visit the company's Chikhalthana unit to rule out any inconsistencies.
The USFDA recently inspected the Wockhardt 's Waluj plant and no serious observations were made says founder and chairman Habil F Khorakiwala.
He further adds that the company has invited the regulator to visit the company's Chikhalthana unit to rule out any inconsistencies.
Transcript to follow soon.
Wockhardt stock price
On February 26, 2015, at 11:13 hrs Wockhardt was quoting at Rs 1562.75, down Rs 42.3, or 2.64 percent. The 52-week high of the share was Rs 1618.15 and the 52-week low was Rs 420.00.
The company's trailing 12-month (TTM) EPS was at Rs 33.45 per share as per the quarter ended December 2014. The stock's price-to-earnings (P/E) ratio was 46.72. The latest book value of the company is Rs 85.15 per share. At current value, the price-to-book value of the company is 18.35.
Anda sedang membaca artikel tentang
No grave observations made in USFDA Waluj visit: Wockhardt
Dengan url
https://olahragakecantikan.blogspot.com/2015/02/no-grave-observations-made-in-usfda.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
No grave observations made in USFDA Waluj visit: Wockhardt
namun jangan lupa untuk meletakkan link
No grave observations made in USFDA Waluj visit: Wockhardt
sebagai sumbernya
0 komentar:
Posting Komentar